drugset / Trial / NCT00005663

A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

NCT00005663

Phase 3 Unknown Glaxo Wellcome
Double-blindTreatment

Summary

The purpose of this study is to see if valacyclovir (Valtrex) is a safe and effective treatment for ano-genital HSV infections (herpes simplex virus infections of the anus and external genitals) in HIV-infected patients.

Timeline

Start
1999-06
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Valacyclovir Unknown